Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system

Sawako Tabuchi1, Tomomi Tsunematsu, Sarah W Black

  • 1Research Institute of Environmental Medicine, Nagoya University, Nagoya, 464-8601, Japan, Department of Physiological Sciences, The Graduate University for Advanced Studies, Okazaki 444-8585, Japan, Japan Society for the Promotion of Science, Tokyo 102-8472, Japan, Center for Neuroscience, Biosciences Division, SRI International, Menlo Park, California 94025, Division of Cell Signaling, National Institute for Physiological Sciences, National Institute of Natural Sciences, Okazaki 444-8787, Japan, Center for Multidisciplinary Brain Research, National Institute for Physiological Sciences, National Institute of Natural Sciences, Okazaki 444-8585, Japan, Division of Endocrinology and Metabolism, National Institute for Physiological Sciences, National Institute of Natural Sciences, Okazaki 444-8585, Japan, and Department of Molecular Neuroscience and Integrative Physiology, Faculty of Medicine, Kanazawa University, Kanazawa, Ishikawa 920-8640, Japan.

Insights

A new mouse model mimics human narcolepsy by targeting orexin/hypocretin neurons postpubertally. This model shows rapid cell loss, cataplexy, and metabolic changes, offering insights into narcolepsy and related functions.

Area of Science:

  • Neuroscience
  • Sleep Medicine
  • Genetics

Background:

  • Narcolepsy is a sleep disorder caused by the loss of orexin/hypocretin neurons in the hypothalamus.
  • Existing mouse models of narcolepsy typically involve early-onset genetic defects, not reflecting the postpubertal onset common in humans.

Purpose of the Study:

  • To develop a novel mouse model that more accurately replicates the postpubertal onset and progression of human narcolepsy.
  • To investigate the effects of targeted orexin neuron loss on sleep architecture, cataplexy, and metabolic functions.

Main Methods:

  • Utilized a Tet-off system to control the expression of diphtheria toxin A (DTA) in orexin neurons.
  • Administered doxycycline to regulate DTA expression and induce targeted neurodegeneration in adult mice.
  • Monitored sleep patterns, observed for cataplexy, and measured body weight and food consumption.

Main Results:

  • Doxycycline removal led to rapid (80% within 7 days) loss of orexin neurons in adult mice.
  • Disrupted sleep architecture and the development of cataplexy were observed.
  • Induced weight gain without altered food intake, mirroring metabolic disturbances in human narcolepsy.

Conclusions:

  • The developed Tet-off DTA mouse model provides a faithful representation of postpubertal narcolepsy onset and progression.
  • This model is valuable for studying the pathophysiology of narcolepsy, including cataplexy and metabolic dysregulation.
  • It serves as a platform for pharmacological interventions and research into network reorganization following orexin system loss.